MUC16 and breast carcinoma: For example, FAM83A (2.4-fold decrease) is an oncogene that activates CRAF/MAPK signaling and drives epithelial transformation52, while MUC16 (2.3-fold decrease) is a tumor marker that induces breast cancer cell proliferation by interacting with JAK221.